Recently published research from Global Markets Direct, "Otsuka Holdings Co., Ltd. - Product Pipeline Review - 2013", is now available at Fast Market Research

Boston, MA -- (SBWire) -- 08/20/2013 --Global Markets Direct's pharmaceuticals report, "Otsuka Holdings Co., Ltd. - Product Pipeline Review - 2013" provides data on the Otsuka Holdings Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Otsuka Holdings Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Otsuka Holdings Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Otsuka Holdings Co., Ltd. - Brief Otsuka Holdings Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Otsuka Holdings Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Otsuka Holdings Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Otsuka Holdings Co., Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Otsuka Holdings Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Otsuka Holdings Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Otsuka Holdings Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Otsuka Holdings Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Otsuka Holdings Co., Ltd. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Otsuka Holdings Co., Ltd.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Otsuka Holdings Co., Ltd. - Product Pipeline Review - 2013
- Otsuka Holdings Co., Ltd. - Product Pipeline Review - 2012
- Samyang Holdings Corporation - Product Pipeline Review - 2013
- Sareum Holdings plc - Product Pipeline Review - 2013
- Circassia Holdings Ltd. - Product Pipeline Review - 2013
- Amura Holdings Ltd. - Product Pipeline Review - 2013
- Obio Pharmaceutical Holdings Limited - Product Pipeline Review - 2013
- Epistem Holdings Plc - Product Pipeline Review - 2013
- Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - 2013
- Neuroblastoma - Pipeline Review, H2 2013